Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-025050
Filing Date
2024-10-11
Accepted
2024-10-11 19:08:12
Documents
1
Period of Report
2024-10-09

Document Format Files

Seq Description Document Type Size
1 form4-10112024_111008.html 4  
1 form4-10112024_111008.xml 4 3884
  Complete submission text file 0001415889-24-025050.txt   5499
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Issuer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 155 RANCHRIDGE DRIVE NW CALGARY, ALBERTA Z4 T3G 1W1
Business Address
Facchini Peter J. (Reporting) CIK: 0001883966 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38286 | Film No.: 241368705